Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Telerehabilitation in Hemato-oncological Survivors

NCT: NCT05779605 · COMPLETED

NCT IDNCT05779605
StatusCOMPLETED
Start Date2023-04-01
Completion2026-09-29
SponsorBrno University Hospital (OTHER)
First posted
Last updated

Brief Summary

This study investigates whether the 12-week home-based exercise training with remote guidance and telemonitoring compared to regular center-based training leads to better long-term cardiorespiratory fitness and physical activity levels in post-treatment patients with lymphoma.

Frequently Asked Questions

What is Telerehabilitation in Hemato-oncological Survivors?

Telerehabilitation in Hemato-oncological Survivors is a clinical trial registered under NCT05779605. Current status: COMPLETED.

What is the status of NCT05779605?

The current status of NCT05779605 (Telerehabilitation in Hemato-oncological Survivors) is: COMPLETED.

When did Telerehabilitation in Hemato-oncological Survivors start?

Telerehabilitation in Hemato-oncological Survivors started on 2023-04-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑